Shanghai Fosun Pharmaceutical (Group) announced that its wholly owned subsidiary plans to acquire a 70% stake in a Jinzhou-based medicine company from a Xinjiang-based investment company, at up to RMB 1,365,000,000.
Source:reuters
Welcome to our website. This service is open to member only.
Contact our customer service team
Tel: 86-10-82600828, 82601561
Email: report@researchinchina.com